Matthew Gray, MD
Pain Medicine · Northglenn, CONPI 1396001038
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $7,877 of the $10,713 with a category attached, or 73.5%. It is spread thinly across 25 manufacturers, the largest accounting for just 19.8%. 2025 is the largest year on record at $3,945, more than ten times the $384 reported in 2019.
Across 208 payments — averaging $51.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$2K
- Nevro Corp.$2K
- Medtronic$1K
- Boston Scientific$1K
- AbbVie$799
- MML US, Inc.$770
- plus $2K from 19 others
What the payments were for
- Travel & lodging$2,83626%
- Food & beverage$7,87774%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 19 | $2,119 |
| Nevro Corp. | 32 | $2,021 |
| Medtronic(2 entities) | 14 | $1,424 |
| Boston Scientific | 28 | $1,243 |
| AbbVie(2 entities) | 40 | $799 |
| MML US, Inc. | 7 | $770 |
| Saluda Medical Americas, Inc. | 5 | $390 |
| Bausch & Lomb Americas Inc. | 15 | $350 |
| SPR Therapeutics, Inc | 4 | $293 |
| Globus Medical | 7 | $289 |
| Nalu Medical, Inc. | 1 | $149 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $128 |
| Stryker | 1 | $122 |
| Collegium Pharmaceutical, Inc. | 6 | $102 |
| Relievant Medsystems, Inc. | 1 | $96 |
| Pfizer | 4 | $93 |
| Scilex Pharmaceuticals Inc. | 6 | $86 |
| Biohaven Pharmaceuticals, Inc. | 5 | $79 |
| Biohaven Pharmaceutical Holding Company Ltd. | 2 | $46 |
| Sun Pharmaceutical Industries Inc. | 2 | $31 |
| Ipsen Biopharmaceuticals, Inc | 1 | $21 |
| Dompe US, Inc. | 1 | $18 |
| IBSA Pharma Inc. | 1 | $16 |
| Oyster Point Pharma, Inc. | 1 | $14 |
| Vertex | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- PROCLAIM$1,644
- Omnia$892
- VANTA ADAPTIVESTIM$712
- ReActiv8$605
- Evoke$344
- Intracept$324
- SPRINT PNS System$230
- INCEPTIV$161
- Nalu Neurostimulation System$149
- INTELLIS$143
- Senza$143
- GENERAL - THERAPIES$143
- ETERNA$140
- SPECTRA WAVEWRITER$124
- OPTABLATE$122
- enVista MX60 IOL$121
- GENERAL PAIN MANAGEMENT$114
How this compares
$10,713 in reported general payments places this provider in the 80th percentile of 96 pain medicine providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other pain medicine in Northglenn
- Robert MoghimGolden$273K
- Jack RentzGreenwood Village$264K
- Donald BernardiniEnglewood$102K
- Haley BurkeAurora$55K
- Amar PatelThornton$47K
- David ColumbusLoveland$30K
- Matthew PouliotFort Collins$26K
- Justin MerkowEnglewood$24K
- Daniel FeldmanBroomfield$18K
- Steven WrightWheat Ridge$18K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.